Skip to main content
TipRanks
Go Ultimate75% OFF

Youngbo Chemical Co., Ltd. (014440) AI Stock Analysis

KR:014440

Youngbo Chemical Co., Ltd.

(Korea Exchange:014440)

Select Model
Rating:85Outperform
Price Target:KRW 5,570.00▲(19.40% Upside)
Action:initiatedcoverage
Date:10/28/26

The score is driven primarily by strong financial quality (notably low leverage and solid profitability) and very compelling valuation (low P/E and high dividend yield). Technicals add support with price above key moving averages and positive MACD, though elevated stochastic suggests some short-term extension risk.

Positive Factors
Very low leverageThe near-zero debt burden gives Youngbo Chemical substantial financial flexibility and low solvency risk. A conservative balance sheet can help the company withstand weaker demand, preserve borrowing capacity, and continue funding operations or investment without significant interest pressure.
Negative Factors
Modest recent revenue growthRecent top-line expansion appears incremental rather than rapid, which may limit operating leverage and the pace at which earnings can compound. The company has improved since 2023, but modest current growth leaves results more dependent on maintaining profitability than on broad-based sales expansion.

Youngbo Chemical Co., Ltd. (014440) vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%KR:014440+11.02%SPY+13.31%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
KRW 91.55B
Dividend Yield
7.45%
Average Volume (3M)
14.98K
Price to Earnings (P/E)
5.0
Beta (1Y)
-0.05
Revenue Growth
6.64%
EPS Growth
2.60%
Country
KR
Employees
234
Sector
General
Sector Strength
55
Industry
Chemicals

Youngbo Chemical Co., Ltd. Business Overview & Revenue Model

Company Description

Youngbo Chemical Co., Ltd. is a global producer and distributor specializing in cross-linked polyolefin foam. The company offers a comprehensive line of products, marketed under brand names such as Artiflex, Artilon, Epilon, Heatlon, Filmy, Polyisocy...

Youngbo Chemical Co., Ltd. Financial Statement Overview

Summary

Strong overall fundamentals: profitability is healthy and improved materially versus 2021–2022, the balance sheet is extremely conservative with near-zero leverage, and cash flow has rebounded with positive free cash flow. Offsetting factors include only modest recent revenue growth, margins below the 2024 peak, and historically uneven free-cash-flow conversion despite the recent improvement.

Income Statement

86Very Positive

Balance Sheet

92Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue125.33B120.11B117.57B90.28B82.99B99.74B
Gross Profit36.83B36.89B35.96B22.80B20.26B24.47B
EBITDA29.78B28.19B30.56B15.40B16.34B12.78B
Net Income18.29B16.83B22.55B5.96B6.69B3.50B
Balance Sheet
Total Assets216.31B210.74B202.58B179.04B180.45B179.90B
Cash, Cash Equivalents and Short-Term Investments47.51B51.79B51.04B41.30B38.58B35.92B
Total Debt236.07M217.04M204.66M2.24B9.73B8.90B
Total Liabilities19.03B19.44B19.72B15.17B22.01B24.69B
Stockholders Equity197.28B191.29B182.86B163.86B158.44B155.21B
Cash Flow
Free Cash Flow13.38B7.89B13.98B10.76B-1.66B8.15B
Operating Cash Flow24.02B15.36B21.23B16.42B10.01B16.90B
Investing Cash Flow-22.75B-14.34B-40.66B-9.76B-5.63B-7.40B
Financing Cash Flow-7.05B-7.03B-3.59B-8.77B-956.56M-2.95B

Youngbo Chemical Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price4665.00

Price Trends

50DMA4704.90Negative
100DMA4624.10Positive
200DMA4652.90Positive

Market Momentum

MACD-1.20Positive
RSI49.62Neutral
STOCH55.80Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:014440, the sentiment is Positive. The current price of 4665.00 is below the 20-day moving average (MA) of 4708.50, below the 50-day MA of 4704.90, and above the 200-day MA of 4652.90, indicating a neutral trend. The MACD of -1.20 indicates Positive momentum. The RSI at 49.62 is Neutral, neither overbought nor oversold. The STOCH value of 55.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KR:014440.

Youngbo Chemical Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

KR:014440 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
KR:014440KR:01444085OutperformKRW 91.55B5.00―7.45%6.64%2.60%
KR:015890KR:01589065NeutralKRW 133.87B3.65―5.46%17.96%49.64%
KR:023450KR:02345065NeutralKRW 99.98B8.93―5.37%16.98%60.57%
KR:102260KR:10226061NeutralKRW 166.94B4.08―4.46%8.07%33.39%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
KR:051630KR:05163055NeutralKRW 104.94B64.58――-13.87%―
KR:006840KR:00684042NeutralKRW 92.62B-1.69――――

* General Sector Average

Performance Comparison

-50%0%50%KR:014440KR:006840KR:015890KR:023450KR:051630KR:102260Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
KR:014440 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
KR:014440Youngbo Chemical Co., Ltd.4665.00458.3010.89%
KR:006840AK Holdings, Inc.7120.00-2140.00-23.11%
KR:015890Taekyung Industrial Co., Ltd.4555.00-261.26-5.42%
KR:023450Dongnam Chemical Co., Ltd.28300.00-905.99-3.10%
KR:051630Chin Yang Chemical Corp.5010.002340.0087.64%
KR:102260DONGSUNG CHEMICAL Co., Ltd.3435.00-528.01-13.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026